title: Ancrod for coronary angioplasty.
abstract: Anticoagulation in the form of intravenous heparin is used after coronary angioplasty to prevent thrombosis. Ancrod, a rapid-acting defibrinogenating agent, has been used in various clinical settings that require anticoagulation. We present the use of ancrod after percutaneous transluminal coronary angioplasty in a patients with heparin-induced thrombopathia.
authors.affiliation: Department of Internal Medicine, Medical College of Ohio, Toledo 43699, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Pothoulakis
authors.forename: S K
authors.initials: SK
authors.lastname: Neerukonda
authors.forename: G
authors.initials: G
authors.lastname: Ansel
authors.forename: R D
authors.initials: RD
authors.lastname: Jantz
mesh_terms: D000368:Aged; D000721:Ancrod / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006801:Humans
chemical_list: D000925:Anticoagulants; D006493:Heparin; D000721:Ancrod